SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-009849
Filing Date
2023-03-30
Accepted
2023-03-30 17:25:28
Documents
13
Period of Report
2023-03-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39269
2 ex99-1.htm EX-99.1 14497
  Complete submission text file 0001493152-23-009849.txt   234767

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE invo-20230330.xsd EX-101.SCH 3245
4 XBRL LABEL FILE invo-20230330_lab.xml EX-101.LAB 34916
5 XBRL PRESENTATION FILE invo-20230330_pre.xml EX-101.PRE 22801
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3643
Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240
Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505
INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)

IRS No.: 204036208 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39701 | Film No.: 23781879
SIC: 3841 Surgical & Medical Instruments & Apparatus